z-logo
open-access-imgOpen Access
An Emerging Minimally Invasive Ozone Therapy for Spinal Disc Disease and Its Outcome
Author(s) -
Fahmida Arab Mallah,
Syed Aamir Shah,
Imran Mirbaher,
Muzamil Dilbar,
Abdul Razaque Mari,
. Obaidullah
Publication year - 2022
Publication title -
pakistan journal of neurological surgery
Language(s) - English
Resource type - Journals
eISSN - 2409-5567
pISSN - 1995-8811
DOI - 10.36552/pjns.v26i1.648
Subject(s) - medicine , ozone therapy , neurosurgery , degenerative disc disease , magnetic resonance imaging , lumbar , surgery , visual analogue scale , neck pain , spinal stenosis , spinal canal stenosis , prospective cohort study , spinal canal , radiology , spinal cord , pathology , alternative medicine , psychiatry
Objectives:  To analyze the effect and outcome of ozone therapy in herniated cervical and lumbar disc disease. Material and Methods:  A prospective study was conducted in the Neurosurgery Department of Federal Medical, Teaching Hospital Islamabad from March 2015 to December 2019. 310 patients with neck ache, and backache with radiculopathy were enrolled. Magnetic resonance imaging and the computed tomographic scan were done.4 to 6 ml of ozone were inserted in disc space. Periodic follow-up was done for up to 6 months of therapy. A single session of therapy was required in 55%, twice in 22.5%, and multiple in 13% of patients. Results:  Out of 310 patients, n = 220 were male and 90 females. Cervical herniated discs were 30 and lumbar 280, single cervical disc herniation was found in n = 26 and multiple in n = 4 while the single-level herniated lumbar disc was n = 220 and multiple in n = 60. Self-analysis of pain before intervention was assessed by visual analog, scored was VAS 4 in n = 80, VAS 5 – 6 in n = 120, VAS 7 – 9 in n = 70, and VAS 10 in n = 40 patients. Post-intervention prognosis according to Modified Mac nab was Excellent in 54%, good in 29%, Fair in 13%, and poor in 3.2% of patients.  

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here